Mariko Kobayashi

Toranomon, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 139 publications

Renin-related changes after sequential switching from aliskiren to valsartan and sacubitril/valsartan in patients with a high-renin phenotype: a prospective pilot study.

Renin-related changes after sequential switching from aliskiren to valsartan and sacubitril/valsartan in patients with a high-renin phenotype: a prospective pilot study.

Journal: Clinical and experimental nephrology

Published: May 31, 2026

Serum microRNA-122 Is Associated with the Therapeutic Response to Diet and Exercise Therapy in Patients with Steatotic Liver Disease.

Serum microRNA-122 Is Associated with the Therapeutic Response to Diet and Exercise Therapy in Patients with Steatotic Liver Disease.

Journal: Internal medicine (Tokyo, Japan)

Published: May 06, 2026

Serum MicroRNA-122 Predicts Early Progressive Disease in Unresectable Hepatocellular Carcinoma with Atezolizumab plus Bevacizumab Therapy.

Serum MicroRNA-122 Predicts Early Progressive Disease in Unresectable Hepatocellular Carcinoma with Atezolizumab plus Bevacizumab Therapy.

Journal: Oncology

Published: January 22, 2026

Diagnostic Pathways and Outcomes of First-Line Atezolizumab plus Bevacizumab in Patients with Locoregional Therapy-Ineligible Hepatocellular Carcinoma at Initial Diagnosis.

Diagnostic Pathways and Outcomes of First-Line Atezolizumab plus Bevacizumab in Patients with Locoregional Therapy-Ineligible Hepatocellular Carcinoma at Initial Diagnosis.

Journal: Oncology

Published: January 21, 2026

Balloon-occluded Infusion of Fragmented Gelatin Particles of Transarterial Embolization for Hypervascular Hepatic Metastases: A Prospective Trial.

Balloon-occluded Infusion of Fragmented Gelatin Particles of Transarterial Embolization for Hypervascular Hepatic Metastases: A Prospective Trial.

Journal: Anticancer research

Published: January 16, 2026

Transcription factor PITX2 protects intestinal epithelial cells against inflammatory stress: Implications for ulcerative colitis rectal predilection and therapeutic resistance.

Transcription factor PITX2 protects intestinal epithelial cells against inflammatory stress: Implications for ulcerative colitis rectal predilection and therapeutic resistance.

Journal: Biochemical and biophysical research communications

Published: January 15, 2026

The Central Role of Liver Function at Treatment Initiation and Its Preservation at Progression for Post-Progression Survival After Atezolizumab Plus Bevacizumab in Advanced Hepatocellular Carcinoma.

The Central Role of Liver Function at Treatment Initiation and Its Preservation at Progression for Post-Progression Survival After Atezolizumab Plus Bevacizumab in Advanced Hepatocellular Carcinoma.

Journal: Biomedicines

Published: December 14, 2025

Safety and Effectiveness of Glecaprevir/Pibrentasvir in Children and Adolescents With Chronic Hepatitis C: Reports From All-Case Post-Marketing Surveillance in Japan.

Safety and Effectiveness of Glecaprevir/Pibrentasvir in Children and Adolescents With Chronic Hepatitis C: Reports From All-Case Post-Marketing Surveillance in Japan.

Journal: Hepatology research : the official journal of the Japan Society of Hepatology

Published: November 11, 2025

Biomarker-Based Responder Selection and Early Prediction of Treatment Response in Hepatocellular Carcinoma: Dynamic Changes in Alpha-Fetoprotein and Des-Gamma-Carboxy Prothrombin During Atezolizumab Plus Bevacizumab Therapy.

Biomarker-Based Responder Selection and Early Prediction of Treatment Response in Hepatocellular Carcinoma: Dynamic Changes in Alpha-Fetoprotein and Des-Gamma-Carboxy Prothrombin During Atezolizumab Plus Bevacizumab Therapy.

Journal: Cancers

Published: October 26, 2025

Exploratory Clinical Study to Evaluate the Efficacy and Safety of Sulfasalazine for Immune Checkpoint Inhibitor (ICI)-Induced Colitis.

Exploratory Clinical Study to Evaluate the Efficacy and Safety of Sulfasalazine for Immune Checkpoint Inhibitor (ICI)-Induced Colitis.

Journal: JGH open : an open access journal of gastroenterology and hepatology

Published: October 21, 2025

A Clinical Trial to Evaluate the Safety and Efficacy of Centella asiatica for Ulcerative Colitis.

A Clinical Trial to Evaluate the Safety and Efficacy of Centella asiatica for Ulcerative Colitis.

Journal: JGH open : an open access journal of gastroenterology and hepatology

Published: July 10, 2025

Association of concomitant proton pump inhibitor use with worse survival outcomes in patients with advanced gastric cancer receiving ramucirumab.

Association of concomitant proton pump inhibitor use with worse survival outcomes in patients with advanced gastric cancer receiving ramucirumab.

Journal: British journal of clinical pharmacology

Published: May 16, 2025

Showing 1-12 of 139

Last Updated: 09/26/2026